These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38343533)

  • 1. Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?
    Pérez de la Lastra JM; Anand U; González-Acosta S; López MR; Dey A; Bontempi E; delaNuez AM
    Front Immunol; 2024; 15():1365827. PubMed ID: 38343533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?
    Pérez de la Lastra JM; Anand U; González-Acosta S; López MR; Dey A; Bontempi E; Morales delaNuez A
    Front Immunol; 2022; 13():921483. PubMed ID: 35720330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workers.
    Decru B; Van Elslande J; Steels S; Van Pottelbergh G; Godderis L; Van Holm B; Bossuyt X; Van Weyenbergh J; Maes P; Vermeersch P
    Front Immunol; 2022; 13():1098285. PubMed ID: 36505436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19.
    Adhikari B; Bednash JS; Horowitz JC; Rubinstein MP; Vlasova AN
    Front Immunol; 2024; 15():1384209. PubMed ID: 38482012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
    Santos IKFM; Costa CHN
    Front Immunol; 2020; 11():615628. PubMed ID: 33224154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.
    Tsilika M; Taks E; Dolianitis K; Kotsaki A; Leventogiannis K; Damoulari C; Kostoula M; Paneta M; Adamis G; Papanikolaou I; Stamatelopoulos K; Bolanou A; Katsaros K; Delavinia C; Perdios I; Pandi A; Tsiakos K; Proios N; Kalogianni E; Delis I; Skliros E; Akinosoglou K; Perdikouli A; Poulakou G; Milionis H; Athanassopoulou E; Kalpaki E; Efstratiou L; Perraki V; Papadopoulos A; Netea MG; Giamarellos-Bourboulis EJ
    Front Immunol; 2022; 13():1018384. PubMed ID: 36119100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
    Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
    Front Immunol; 2023; 14():1208659. PubMed ID: 37292214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Activity of the Serum before and after Vaccination with EpiVacCorona.
    Arzumanyan VG; Bystritskaya EP; Kolyganova TI; Iksanova AM; Samoilikov PV; Konanykhina SY; Vartanova AA; Svitich OA
    Bull Exp Biol Med; 2022 Jul; 173(3):354-360. PubMed ID: 35852689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID.
    Goh D; Lim JCT; Fernaíndez SB; Joseph CR; Edwards SG; Neo ZW; Lee JN; Caballero SG; Lau MC; Yeong JPS
    Front Immunol; 2022; 13():1036894. PubMed ID: 36275692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy.
    Hasankhani A; Bahrami A; Tavakoli-Far B; Iranshahi S; Ghaemi F; Akbarizadeh MR; Amin AH; Abedi Kiasari B; Mohammadzadeh Shabestari A
    Front Immunol; 2024; 15():1422261. PubMed ID: 38779659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: The effects of COVID-19 on the placenta during pregnancy.
    Rad HS; Röhl J; Stylianou N; Allenby MC; Bazaz SR; Warkiani ME; Guimaraes FSF; Clifton VL; Kulasinghe A
    Front Immunol; 2022; 13():998406. PubMed ID: 36159853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.
    Moreira TG; Matos KTF; De Paula GS; Santana TMM; Da Mata RG; Pansera FC; Cortina AS; Spinola MG; Baecher-Allan CM; Keppeke GD; Jacob J; Palejwala V; Chen K; Izzy S; Healey BC; Rezende RM; Dedivitis RA; Shailubhai K; Weiner HL
    Front Immunol; 2021; 12():815812. PubMed ID: 35095916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequelae of SARS-CoV-2 infection.
    Dean LS; Devendra G; Jiyarom B; Subia N; Tallquist MD; Nerurkar VR; Chang SP; Chow DC; Shikuma CM; Park J
    Front Immunol; 2023; 14():1209624. PubMed ID: 37187732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Cross-reactive humoral and CD4
    Martel F; Cuervo-Rojas J; Ángel J; Ariza B; González JM; Ramírez-Santana C; Acosta-Ampudia Y; Murcia-Soriano L; Montoya N; Cardozo-Romero CC; Valderrama-Beltrán SL; Cepeda M; Castellanos JC; Gómez-Restrepo C; Perdomo-Celis F; Gazquez A; Dickson A; Brien JD; Mateus J; Grifoni A; Sette A; Weiskopf D; Franco MA
    Front Immunol; 2023; 14():1274753. PubMed ID: 37662943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity.
    Razonable RR
    Front Immunol; 2024; 15():1440571. PubMed ID: 39119333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.
    Tajuelo A; Carretero O; García-Ríos E; López-Siles M; Cano O; Vázquez M; Más V; Rodríguez-Goncer I; Lalueza A; López-Medrano F; San Juan R; Fernández-Ruiz M; Aguado JM; McConnell MJ; Pérez-Romero P
    Front Immunol; 2022; 13():965809. PubMed ID: 35990649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Epigenetic immune monitoring for COVID-19 disease course prognosis.
    Samans B; Rosselló Chornet M; Rosselló Chornet A; Jung J; Schildknecht K; Lozza L; Alos Zaragoza L; Hernández Laforet J; Babel N; Olek S
    Front Immunol; 2024; 15():1451571. PubMed ID: 38994367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia.
    Jeon K; Kim Y; Kang SK; Park U; Kim J; Park N; Koh J; Shim MS; Kim M; Rhee YJ; Jeong H; Lee S; Park D; Lim J; Kim H; Ha NY; Jo HY; Kim SC; Lee JH; Shon J; Kim H; Jeon YK; Choi YS; Kim HY; Lee WW; Choi M; Park HY; Park WY; Kim YS; Cho NH
    Front Immunol; 2023; 14():1175767. PubMed ID: 36969212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients.
    Giron LB; Dweep H; Yin X; Wang H; Damra M; Goldman AR; Gorman N; Palmer CS; Tang HY; Shaikh MW; Forsyth CB; Balk RA; Zilberstein NF; Liu Q; Kossenkov A; Keshavarzian A; Landay A; Abdel-Mohsen M
    Front Immunol; 2021; 12():779064. PubMed ID: 34671365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: an individual-level analysis within 13 months in the ORCHESTRA cohort.
    Collatuzzo G; De Palma G; Violante FS; Porru S; Filon FL; Fabianova E; Violán C; Vimercati L; Leustean M; Rodriguez-Suarez MM; Sansone E; Sala E; Zunarelli C; Lodi V; Monaco MGL; Spiteri G; Negro C; Beresova J; Carrasco-Ribelles LA; Tafuri S; Asafo SS; Ditano G; Abedini M; Boffetta P
    Front Immunol; 2023; 14():1197923. PubMed ID: 37122701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.